.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Colorcon
Daiichi Sankyo
Chinese Patent Office
Boehringer Ingelheim
Julphar
Teva
Cerilliant
Farmers Insurance
Johnson and Johnson

Generated: February 19, 2018

DrugPatentWatch Database Preview

Patents Expiring in August 2024

« Back to Dashboard

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Endo Pharms IncNASCOBALcyanocobalaminSPRAY, METERED;NASAL021642-001Jan 31, 2005RXYesYes➤ Sign Up➤ Sign UpNASAL ADMINISTRATION OF CYANOCOBALAMIN
Endo Pharms IncNASCOBALcyanocobalaminSPRAY, METERED;NASAL021642-001Jan 31, 2005RXYesYes➤ Sign Up➤ Sign UpYCYANOCOBALAMIN ADMINISTRATION THROUGH NASAL INFUSION
Endo Pharms IncNASCOBALcyanocobalaminSPRAY, METERED;NASAL021642-001Jan 31, 2005RXYesYes➤ Sign Up➤ Sign UpYNASAL ADMINISTRATION OF CYANOCOBALAMIN
Allergan IncRHOFADEoxymetazoline hydrochlorideCREAM;TOPICAL208552-001Jan 18, 2017RXYesYes➤ Sign Up➤ Sign UpTOPICAL TREATMENT OF PERSISTENT FACIAL ERYTHEMA ASSOCIATED WITH ROSACEA IN ADULTS WITH 1% OXYMETAZOLINE HYDROCHLORIDE CREAM
AllerganACUVAILketorolac tromethamineSOLUTION/DROPS;OPHTHALMIC022427-001Jul 22, 2009RXYesYes➤ Sign Up➤ Sign UpY
Endo PharmsOPANA ERoxymorphone hydrochlorideTABLET, EXTENDED RELEASE;ORAL201655-002Dec 9, 2011DISCNYesNo➤ Sign Up➤ Sign UpY
Endo PharmsOPANA ERoxymorphone hydrochlorideTABLET, EXTENDED RELEASE;ORAL201655-001Dec 9, 2011DISCNYesNo➤ Sign Up➤ Sign UpY
Endo PharmsOPANA ERoxymorphone hydrochlorideTABLET, EXTENDED RELEASE;ORAL201655-007Dec 9, 2011DISCNYesNo➤ Sign Up➤ Sign UpY
Endo PharmsOPANA ERoxymorphone hydrochlorideTABLET, EXTENDED RELEASE;ORAL201655-006Dec 9, 2011DISCNYesNo➤ Sign Up➤ Sign UpY
Endo PharmsOPANA ERoxymorphone hydrochlorideTABLET, EXTENDED RELEASE;ORAL201655-005Dec 9, 2011DISCNYesNo➤ Sign Up➤ Sign UpY
This preview shows a limited number of results
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Medtronic
Colorcon
US Department of Justice
Dow
Fuji
UBS
Teva
Accenture
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot